ReviewFrontiers in pharmacology2025
Multimodal integration strategies for clinical application in oncology.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Review
- The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review).International journal of oncology · 2026Review
- Machine Learning for Radiomics in Oncology: Challenges, Limitations, and Future Directions.Sensors (Basel, Switzerland) · 2026Article
- Article
- Article
- Multimodal artificial intelligence and machine learning in oncology: from data integration to precision cancer care.Frontiers in digital health · 2026Review
- AI-enabled D-dimeromics in precision breast oncology: a transformative framework for the identification, stratification, and prognostication of ultra-high-risk disease phenotypes.Frontiers in oncology · 2026Review
- Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions.Frontiers in oncology · 2026Review
- Artificial Intelligence in Traditional Chinese Medicine: Unraveling Herbal Medicine's Mechanisms.Research (Washington, D.C.) · 2026Review
- Multimodal AI in high-grade serous ovarian cancer: integrated prediction and clinical decision-making.Frontiers in oncology · 2026Review
- The Emerging Role of Multimodal Artificial Intelligence in Urological Surgery.Current oncology (Toronto, Ont.) · 2025Review
- Translating Features to Findings: Deep Learning for Melanoma Subtype Prediction.Dermatopathology (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In clinical practice, a variety of techniques are employed to generate diverse data types for each cancer patient. These data types, spanning clinical, genomics, imaging, and other modalities, exhibit significant differences and possess distinct data structures. Therefore, most current analyses focus on a single data modality, limiting the potential of fully utilizing all available data and providing comprehensive insights. Artificial intelligence (AI) methods, adept at handling complex data structures, offer a powerful approach to efficiently integrate multimodal data. The insights derived from such models may ultimately expedite advancements in patient diagnosis, prognosis, and treatment responses. Here, we provide an overview of current advanced multimodal integration strategies and the related clinical potential in oncology field. We start from the key processing methods for single data modalities such as multi-omics, imaging data, and clinical notes. We then include diverse AI methods, covering traditional machine learning, representation learning, and vision language model, tailored to each distinct data modality. We further elaborate on popular multimodal integration strategies and discuss the related strength and weakness. Finally, we explore potential clinical applications including early detection/diagnosis, biomarker discovery, and prediction of clinical outcome. Additionally, we discuss ongoing challenges and outline potential future directions in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.